NCT05894876View on ClinicalTrials.gov

A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature

TerminatedOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

April 29, 2024

Primary Completion Date

March 21, 2025

Study Completion Date

March 21, 2025

Conditions
Idiopathic Short Stature
Interventions
OTHER

No treatment is given

No treatment is provided to the participants as part of this study.

Trial Locations (2)

21044

Novo Nordisk Investigational Site, Columbia

05403-908

University of Sao Paulo School of Medicine, São Pauloa

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT05894876 - A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature | Biotech Hunter | Biotech Hunter